Stay Updated with the Latest Medalist Diversified REIT, Inc. MDRR News in Real Time
Find MDRR news now at Meyka AI. Stay informed with the latest Medalist Diversified REIT, Inc. stocks updates, including price news, market analysis, and expert insights.
Robinhood Stock Rises 4.63% to $95.77 as MSTR, COIN and CRCL Rally on Treasury Buyback
Robinhood stock closed at $95.77 on August 19, 2026, up 4.63% for the session. Strategy, Coinbase, and Circle all posted stronger gains the same day. The U.S. Treasury’s expanded bond buyback program eased yields and lifted risk appetite across crypto-linked equities. Bitcoin climbed above $68,000, extending gains into $71,600 territory by Thursday morning. Why Robinhood…
Crypto Prices Today: Bitcoin Hits $69,551, Ethereum Gains 17.74% as Hyperliquid Surges 20.97%
Crypto prices surged sharply on Thursday, August 20, 2026, breaking weeks of sideways trading. Bitcoin jumped to $69,551, gaining roughly 8% in 24 hours. Ethereum climbed 17.74% to reclaim the $2,000 level, while Hyperliquid’s HYPE token surged 20.97%. The rally followed a surprise US Treasury announcement to double its long-dated bond buyback operations. Total crypto…
NVDA Stock, AMD Stock, Micron and Broadcom Gain as AI Spending Estimates Rise
AI spending estimates are rising again, giving semiconductor stocks a fresh boost. On August 7, 2026, Goldman Sachs estimated global AI investment could reach about $1 trillion this year, above widely cited hyperscaler spending forecasts. That outlook is supporting demand for AI chips, memory and networking hardware. As a result, NVDA stock, AMD stock, Micron…
Strides Pharma Stock Rallies 10% as USFDA Concludes Bengaluru Inspection
Strides Pharma shares surged 11% to ₹1,055.90 on the BSE on August 20, 2026. The rally followed news that the company’s flagship Bengaluru facility received a USFDA Establishment Inspection Report. That report confirms successful closure of a cGMP inspection conducted in May 2026. Heavy trading volumes accompanied the sharp intraday move. What the USFDA EIR…
Gaja Alternative IPO GMP Today: How Gaja Capital Is Challenging the AIF Model
Gaja Alternative IPO’s Grey Market Premium stood at ₹21 as of Thursday, August 20, 2026, 9:45 AM IST. That implies a listing price near ₹181, a 13% premium over the ₹160 upper band. The ₹550 crore issue from Gaja Capital’s asset management arm closes for subscription on August 21. Overall subscription remained modest at 0.30…
Apple iPhone 17 Pro Max Price Drops to ₹1,03,300 in India With ₹9,000 Bank Offer and Exchange Deal
The iPhone 17 Pro Max effective price has dropped sharply in India during Flipkart’s Freedom Sale 2026. The 256GB variant now lists at ₹1,41,900, down ₹8,000 from its ₹1,49,900 launch price. With eligible exchange and bank offers combined, buyers can bring the effective price down to around ₹98,300 to ₹1,03,990. How the iPhone 17 Pro…
Nike Stock Drops 4% to 12-Year Low Below $40 as Downgrades and Weak Sales Raise Turnaround Risks
Nike stock faced fresh selling pressure on August 17, 2026, falling about 4% and moving below the $40 mark. The shares touched around $38.85, their lowest level since 2014. Weak sales, softer footwear demand, and new analyst downgrades have added to concerns about Nike’s turnaround. Investors are now watching to see whether the sportswear giant…
AstraZeneca (LON: AZN) Halts Phase 3 Lung Cancer Trial After Volrustomig Fails to Show Survival Benefit
AstraZeneca has halted a late-stage trial of its lung cancer drug Volrustomig, marking a fresh pipeline setback. The FTSE 100 company said the drug, combined with chemotherapy, was unlikely to improve survival rates. An Independent Data Monitoring Committee recommended stopping the Phase 3 trial after a planned review. This marks AstraZeneca’s second major trial halt…
NSE IPO Listings: Molbio Diagnostics, Dhoot Transmission Debut Today; Check GMPs
Two new NSE IPO listings hit the market on Monday, August 17, 2026. Molbio Diagnostics and Dhoot Transmission both made their stock market debuts today. Dhoot Transmission shares surged 37.06% on the NSE, opening at ₹1,193.80. Molbio Diagnostics listed with a smaller but solid 21.44% premium at ₹980. Both companies had commanded strong grey market…